Traditional Chinese Medicine (TCM): Unified Approach for Evaluation

Authored by: Bin Cheng , Shein-Chung Chow

Encyclopedia of Biopharmaceutical Statistics

Print publication date:  August  2018
Online publication date:  August  2018

Print ISBN: 9781498733953
eBook ISBN: 9781351110273
Adobe ISBN:

10.1201/9781351110273-140000077

 Download Chapter

 

Abstract

In recent years, as more and more innovative drug products are going off patent protection, the search for new medicines that treat critical and/or life-threatening diseases such as cardiovascular diseases and cancer has become the center of attention of many pharmaceutical companies and research organizations such as the National Institutes of Health (NIH). This leads to the study of the potential use of promising traditional Chinese medicines (TCMs), especially for critical and/or life-threatening diseases. Randomized clinical trial (RCT) was used to assess the effect of Chinese herb medicine in treating the irritable bowel syndrome.[1] However, RCT is not in common use when studying TCM. There are fundamental differences between Western medicines and TCMs in terms of diagnostic procedures, therapeutic indices, medical mechanism, medical theory, and method practice.[2–4] Besides, TCM often consists of multiple components with flexible dose.

 Cite
Search for more...
Back to top

Use of cookies on this website

We are using cookies to provide statistics that help us give you the best experience of our site. You can find out more in our Privacy Policy. By continuing to use the site you are agreeing to our use of cookies.